Your browser doesn't support javascript.
loading
KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Kammerer, Sarah; Sokolowski, Armin; Hackl, Hubert; Platzer, Dieter; Jahn, Stephan Wenzel; El-Heliebi, Amin; Schwarzenbacher, Daniela; Stiegelbauer, Verena; Pichler, Martin; Rezania, Simin; Fiegl, Heidelinde; Peintinger, Florentia; Regitnig, Peter; Hoefler, Gerald; Schreibmayer, Wolfgang; Bauernhofer, Thomas.
Afiliación
  • Kammerer S; Molecular Physiology Group, Institute of Biophysics, Medical University of Graz, Austria.
  • Sokolowski A; Research Unit on Ion Channels and Cancer Biology, Medical University of Graz, Austria.
  • Hackl H; Molecular Physiology Group, Institute of Biophysics, Medical University of Graz, Austria.
  • Platzer D; Present address: Division of Prosthodontics, Restorative Dentistry, Periodontology and Implantology, Medical University of Graz, Austria.
  • Jahn SW; Division of Bioinformatics, Biocenter, Medical University of Innsbruck, Austria.
  • El-Heliebi A; Molecular Physiology Group, Institute of Biophysics, Medical University of Graz, Austria.
  • Schwarzenbacher D; Institute of Pathology, Medical University of Graz, Austria.
  • Stiegelbauer V; Institute of Cell Biology, Histology and Embryology, Medical University of Graz, Austria.
  • Pichler M; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria.
  • Rezania S; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria.
  • Fiegl H; Division of Oncology, Department of Internal Medicine, Medical University of Graz, Austria.
  • Peintinger F; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Regitnig P; Molecular Physiology Group, Institute of Biophysics, Medical University of Graz, Austria.
  • Hoefler G; Research Unit on Ion Channels and Cancer Biology, Medical University of Graz, Austria.
  • Schreibmayer W; Department of Gynecology and Obstetrics, Medical University of Innsbruck, Austria.
  • Bauernhofer T; Institute of Pathology, Medical University of Graz, Austria.
Oncotarget ; 7(51): 84705-84717, 2016 Dec 20.
Article en En | MEDLINE | ID: mdl-27835900
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Canales de Potasio Rectificados Internamente Asociados a la Proteína G Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Austria
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Biomarcadores de Tumor / Canales de Potasio Rectificados Internamente Asociados a la Proteína G Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Oncotarget Año: 2016 Tipo del documento: Article País de afiliación: Austria